Published in J Endourol on August 01, 2007
Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques? Radiology (2012) 2.18
Tumour location as a predictor of benign disease in the management of renal masses. Can Urol Assoc J (2010) 1.49
MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs. PLoS One (2015) 0.97
Renal adenomas: pathological differential diagnosis with malignant tumors. Adv Urol (2008) 0.87
Differential diagnosis of complex renal cysts based on lesion size along with the Bosniak renal cyst classification. Yonsei Med J (2012) 0.83
Pre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma. Br J Cancer (2009) 0.82
Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer. Mayo Clin Proc (2015) 0.81
Assessment of intratumoral micromorphology for patients with clear cell renal cell carcinoma using susceptibility-weighted imaging. PLoS One (2013) 0.80
The current role of renal biopsy in the management of localized renal tumors. Indian J Urol (2009) 0.79
Incidence and predictive factors of benign renal lesions in Korean patients with preoperative imaging diagnoses of renal cell carcinoma. J Korean Med Sci (2011) 0.79
Human telomerase reverse-transcriptase promoter-controlled and herpes simplex virus thymidine kinase-armed adenoviruses for renal cell carcinoma treatment. Onco Targets Ther (2013) 0.78
Characterization of small renal masses less than 4 cm with quadriphasic multidetector helical computed tomography: differentiation of benign and malignant lesions. Korean J Urol (2012) 0.77
Incidental monotypic (fat-poor) renal angiomyolipoma diagnosed by core needle biopsy. Case Rep Med (2012) 0.76
Metastatic clear cell variant of renal cell carcinoma of the mandible: Review and case report. Ann Maxillofac Surg (2016) 0.75
Clinicians' Real World Perceptions of Pre-Nephrectomy Diagnostic Biopsy Performance as a Driver of Reduction in Unnecessary Surgeries in Renal Tumors. J Kidney Cancer VHL (2015) 0.75
Small Incidental Renal Masses in Adults: Review of the literature. Sultan Qaboos Univ Med J (2010) 0.75
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med (2003) 11.25
Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol (2007) 6.73
Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol (2007) 5.03
A sense of urgency: Evaluating the link between clinical trial development time and the accrual performance of cancer therapy evaluation program (NCI-CTEP) sponsored studies. Clin Cancer Res (2010) 3.66
Ureteroenteric anastomotic strictures after radical cystectomy-does operative approach matter? J Urol (2012) 3.30
A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy. J Urol (2007) 3.26
Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. J Urol (2013) 2.76
Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol (2011) 2.51
Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series. J Urol (2010) 2.39
Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis. BJU Int (2012) 2.37
NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Canc Netw (2010) 2.31
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol (2012) 2.19
Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer. J Urol (2010) 2.03
What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database. J Urol (2008) 2.02
Recovery of urinary function after radical prostatectomy: identification of trajectory cluster groups. J Urol (2012) 1.98
Robotic-assisted laparoscopic prostatectomy: what is the learning curve? Urology (2005) 1.93
Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes. J Urol (2005) 1.89
An internet-based program to improve self-management in adolescents with type 1 diabetes. Diabetes Care (2009) 1.89
Patterns of initial transitional cell recurrence in patients after cystectomy. J Urol (2006) 1.88
Analysis of early complications after radical cystectomy: results of a collaborative care pathway. J Urol (2002) 1.87
National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats. J Urol (2012) 1.84
The influence of health literacy on colorectal cancer screening knowledge, beliefs and behavior. J Natl Med Assoc (2007) 1.79
Volume outcomes of cystectomy--is it the surgeon or the setting? J Urol (2012) 1.77
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study. J Urol (2007) 1.75
Urinary diversion trends at a high volume, single American tertiary care center. J Urol (2009) 1.73
Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate cancer. J Urol (2011) 1.72
Comparison of transfusion requirements between open and robotic-assisted laparoscopic radical prostatectomy. BJU Int (2010) 1.66
Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation. PLoS One (2012) 1.63
Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol (2003) 1.62
Smaller prostate size predicts high grade prostate cancer at final pathology. J Urol (2010) 1.62
Increased body mass index predicts increased blood loss during radical cystectomy. J Urol (2004) 1.58
National practice patterns for immediate postoperative instillation of chemotherapy in nonmuscle invasive bladder cancer. J Urol (2012) 1.58
Whitmoreisms: memorable quotes from Willet F. Whitmore, Jr, M.D. Urology (2004) 1.57
The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a single-surgeon comparison of outcome. Ophthalmology (2003) 1.56
Psychometric characteristics of a condition-specific, health-related quality-of-life survey: the FACT-Vanderbilt Cystectomy Index. Urology (2012) 1.56
Impact of positive apical surgical margins on likelihood of biochemical recurrence after radical prostatectomy. J Urol (2009) 1.55
Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing. J Urol (2013) 1.53
Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients. Urology (2012) 1.53
Comparison of length of hospital stay between radical retropubic prostatectomy and robotic assisted laparoscopic prostatectomy. J Urol (2007) 1.52
Intraoperative blood loss and transfusion requirements for robotic-assisted radical prostatectomy versus radical retropubic prostatectomy. Urology (2006) 1.51
Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer. J Urol (2010) 1.50
Racial variation in the quality of surgical care for bladder cancer. Cancer (2013) 1.45
A clinical pathway for laparoscopic pyeloplasty decreases length of stay. J Urol (2005) 1.44
Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol (2008) 1.44